KO
Kobo Biotech Ltd.
KOBO.BO · BSE
₹4.63 -1.91% (-₹0.09)
1M -9.75%
Market Cap ₹112.5M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/FCF 55.23x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 6.90%
Asset turnover 0.00x
ROIC 2.15%
Debt
0 /100
High Int. coverage -49,287.00x
Current ratio 0.23x
Net debt/EBITDA N/A
Stability
58 /100
Moderate EPS volatility 27.87%
Profitable years 0
Beta 0.50x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KOBO.BO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Neelam Kumar Murdia
Employees
484
Headquarters
Mumbai